Price to Sales ratio Analysis of CytomX Therapeutics Inc - Deep Dive
Latest FY PS
Period Ending - Dec-23
Very Poor PS
1324.54
Period Ending - Dec-22
Indecisive PS
2.10
Growth
62908.35 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Good PS
1.06
PS Analysis of CytomX Therapeutics Inc
P/S Ratio 1.06 of CytomX Therapeutics Inc indicates that stock price is low compared to sales of the company and may be undervalued. |
PS Ratio of CTMX rose handsomely by 62908.35 % this year. |
PS Ratio of CTMX trending up for at least three Years. |
PS Ratio with value of 0.782 was lowest in Year Dec-20 in last Five Years. |
Latest PS Ratio with value of 1324.54 is Greater than Average PS of 265.98 in last five years. |
Other PS Related Info of CTMX that may interest you.
CytomX Therapeutics Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
CTMX | 1.7 | 1.75 | 2.86 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
No Significant Value |
FY - Historical Price to Sales of CytomX Therapeutics Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
PS | 1324.54 | 2.10 | 1.13 | 0.782 | 1.34 | 1.19 | 0.882 |
Change | 62908.35 % | 86.44 % | 44.25 % | -41.70 % | 12.62 % | 34.94 % | -78.46 % |
FY Chart of Price to Sales of CytomX Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)